HK1203359A1 - 酶組合物及其用於創傷癒合的用途 - Google Patents

酶組合物及其用於創傷癒合的用途

Info

Publication number
HK1203359A1
HK1203359A1 HK15103825.8A HK15103825A HK1203359A1 HK 1203359 A1 HK1203359 A1 HK 1203359A1 HK 15103825 A HK15103825 A HK 15103825A HK 1203359 A1 HK1203359 A1 HK 1203359A1
Authority
HK
Hong Kong
Prior art keywords
wound healing
enzyme compositions
enzyme
compositions
healing
Prior art date
Application number
HK15103825.8A
Other languages
English (en)
Inventor
Joan M Fallon
Matthew F Heil
James Szigethy
James Fallon
Original Assignee
Curelon Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curelon Llc filed Critical Curelon Llc
Publication of HK1203359A1 publication Critical patent/HK1203359A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/54Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HK15103825.8A 2012-02-02 2015-04-20 酶組合物及其用於創傷癒合的用途 HK1203359A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261594015P 2012-02-02 2012-02-02
PCT/US2013/024453 WO2013116732A1 (en) 2012-02-02 2013-02-01 Enzyme compositions and use thereof for wound healing

Publications (1)

Publication Number Publication Date
HK1203359A1 true HK1203359A1 (zh) 2015-10-30

Family

ID=48903079

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15103825.8A HK1203359A1 (zh) 2012-02-02 2015-04-20 酶組合物及其用於創傷癒合的用途
HK18104807.5A HK1245130A1 (zh) 2012-02-02 2018-04-12 酶組合物及其用於創傷愈合的用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK18104807.5A HK1245130A1 (zh) 2012-02-02 2018-04-12 酶組合物及其用於創傷愈合的用途

Country Status (6)

Country Link
US (2) US20130202581A1 (zh)
EP (1) EP2809341B1 (zh)
CN (2) CN104220088A (zh)
CA (1) CA2862363C (zh)
HK (2) HK1203359A1 (zh)
WO (1) WO2013116732A1 (zh)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
WO2010002972A1 (en) 2008-07-01 2010-01-07 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
CN105664144B (zh) * 2009-01-06 2020-08-11 加尔纳根有限责任公司 治疗或预防金黄色葡萄球菌感染以及根除或减少表面上金黄色葡萄球菌的组合物和方法
US9084784B2 (en) 2009-01-06 2015-07-21 Curelon Llc Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces
US9056050B2 (en) * 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
WO2011050135A1 (en) 2009-10-21 2011-04-28 Curemark Llc Methods and compositions for the prevention and treatment of influenza
CN103619348B (zh) 2011-04-21 2016-10-26 柯尔马克有限责任公司 用于治疗神经精神障碍的化合物
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
WO2015089461A1 (en) 2013-12-13 2015-06-18 Restorsea, Llc Exfoliative hair retention-promoting formulation
CN106456530A (zh) 2014-05-16 2017-02-22 雷斯托尔西有限公司 双相化妆品
LT6177B (lt) 2014-10-10 2015-07-27 Uab "Biocentras" Fermentų kompleksų išskyrimas iš steptomyces gougerotii 101, daugiafermentinių biopreparatų ruošimas bei taikymas
US9592280B2 (en) * 2014-10-10 2017-03-14 Rochal Industries Llc Compositions and kits for enzymatic debridement and methods of using the same
US20160101166A1 (en) * 2014-10-10 2016-04-14 Rochal Industries, Llp Compositions and kits for treating pruritus and methods of using the same
US10238719B2 (en) 2014-10-10 2019-03-26 Rochal Industries, Llc Compositions and kits for enzymatic debridement and methods of using the same
WO2017035107A1 (en) * 2015-08-24 2017-03-02 Smith & Nephew, Inc. Synergistic antibacterial activity of medium polarity oils in combination with antibacterial agents on bacterial biofilms
AU2017246664B2 (en) * 2016-04-05 2024-01-18 President And Fellows Of Harvard College Fungal species, compositions derived therefrom, and uses thereof
EP3445389B1 (en) * 2016-04-18 2022-10-26 Mediwound Ltd Formulations for debridement of chronic wounds
CN106511399B (zh) * 2016-11-16 2023-12-01 太鲵生物科技(天津)有限公司 一种大鲵粘液的用途
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984002846A1 (en) * 1983-01-21 1984-08-02 Advanced Drug Tech Enzyme ointment
EP1051142A4 (en) * 1997-10-16 2002-01-30 Deguang Zhu NEW STRONG COSMETIC OR PHARMACEUTICAL COMPOSITION
US20020119914A1 (en) * 2000-12-26 2002-08-29 Deguang Zhu New uses of insulin and pancreatin
US6548556B2 (en) * 2000-12-27 2003-04-15 Healthpoint, Ltd. Stable enzymatic wound debrider
US7785584B2 (en) * 2003-08-13 2010-08-31 Healthpoint, Ltd. Ointment wound spray
WO2007074454A2 (en) * 2005-12-27 2007-07-05 Ramot At Tel-Aviv University Ltd. Stable enzymatic preparations and methods of use thereof
ATE518833T1 (de) * 2007-10-26 2011-08-15 Suven Life Sciences Ltd Aminoarylsulfonamidverbindungen und ihre verwendung als 5-ht6-liganden
WO2009155689A1 (en) * 2008-06-24 2009-12-30 Micropharma Limited Nitric oxide device and method for wound healing, treatment of dermatological disorders and microbial infections
CN105664144B (zh) * 2009-01-06 2020-08-11 加尔纳根有限责任公司 治疗或预防金黄色葡萄球菌感染以及根除或减少表面上金黄色葡萄球菌的组合物和方法
US9084784B2 (en) * 2009-01-06 2015-07-21 Curelon Llc Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces

Also Published As

Publication number Publication date
EP2809341A4 (en) 2015-11-11
US20130202581A1 (en) 2013-08-08
CA2862363C (en) 2021-06-08
HK1245130A1 (zh) 2018-08-24
EP2809341B1 (en) 2020-12-30
CA2862363A1 (en) 2013-08-08
CN104220088A (zh) 2014-12-17
CN107261126A (zh) 2017-10-20
WO2013116732A1 (en) 2013-08-08
US20220096611A1 (en) 2022-03-31
EP2809341A1 (en) 2014-12-10

Similar Documents

Publication Publication Date Title
HK1245130A1 (zh) 酶組合物及其用於創傷愈合的用途
EP2916876A4 (en) METHOD AND COMPOSITIONS FOR WOUND HEALING
IL235436A0 (en) Anti-pcsk9 preparations and their use
HK1213798A1 (zh) 治療性化合物和組合物
EP2533772A4 (en) METHOD AND COMPOSITIONS FOR WOUND HEALING
HK1203493A1 (zh) 取代的氮雜雙環及其用途
EP2838954A4 (en) ADHESIVE COMPOSITIONS AND METHODS
HUE044300T2 (hu) 3-amino-cikloalkil-vegyületek, mint ROR-GAMMA-T inhibitorok és alkalmazásuk
ZA201408594B (en) Xylitol-based anti-mucosal compositions and related methods and compositions
EP2884984A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD
EP2849774A4 (en) COMBINATION TREATMENTS AND COMPOSITIONS FOR WOUND HEALING
HK1212251A1 (zh) 局部組合物及其使用方法
HK1203198A1 (zh) 取代的苯基咪唑並吡唑及其用途
EP2895569A4 (en) ADHESIVE COMPOSITIONS AND THEIR USE
HK1201270A1 (zh) 四唑- -基-和三唑- -基-芳基化合物及其作為除草劑的用途
EP2762129A4 (en) COSMETIC COMPOSITION AND COSMETIC PRODUCT
EP2668044A4 (en) COMPOSITIONS AND THEIR USE
EP2895186A4 (en) THERAPEUTIC COMPOSITIONS AND RELATED METHODS
HK1198587A1 (zh) 異噻唑並吡啶- -甲酰胺和它們作為藥物的用途
SG11201502069SA (en) Beta-hydroxy-beta-methylbutryic acid- containing compositions and uses thereof
SI2830587T1 (sl) Sestavek za zaščito in uravnoteženje kože
EP2654793A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF LESIONS
GB201215414D0 (en) Composition and use
AU2012903646A0 (en) Therapeutic methods and compositions
AU2012901350A0 (en) Therapeutic methods and compositions